Organization · Venture Capital

Manta Capital Advisors

Manta Capital Advisors is a venture capital advisory firm that provides strategic guidance and capital investment to early-stage and growth private companies, focusing on life sciences, deep tech, and impact-driven ventures.

Venture CapitalFunder

Official website

Overview

What Manta Capital Advisors does

What Manta Capital Advisors is

How it participates in the startup ecosystem

The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status: Active
Organization type: Venture Capital
Founded: Founded in 2012
Approximate age: About 14 years
Structured capabilities: Funder
Last reviewed: May 5, 2026

Official channels

Find Manta Capital Advisors elsewhere

Open the official website or a supported primary organization account.

Capability profile

Manta Capital Advisors as a funder

Check pitch availability

Investment thesis

Manta Capital Advisors supports early-stage and growth private companies through strategic guidance and capital investment, focusing on life sciences, deep tech, and impact ventures.

Focus narrative

Manta Capital Advisors invests primarily in Life Sciences, Deep Tech, and Impact sectors. The firm seeks to back innovations in healthcare, biotechnology, and medical advancements, as well as cutting-edge technologies such as AI, quantum computing, and robotics. Additionally, Manta focuses on ventures that address global challenges and aim for positive societal and environmental impacts, engaging in club deals and co-investments to enhance the growth potential of its portfolio companies.

Value beyond capital

Manta Capital Advisors adds value to its portfolio companies through strategic guidance, leveraging its extensive network for connections, and facilitating club deals and co-investments with other leading firms. This collaborative approach enhances the growth potential of the companies it supports, ensuring they have access to the necessary resources and expertise to succeed.

Focus and fit

Stages: Seed · Series A · Series B · Series C · Growth Equity
Sectors: Biotech & Life Sciences Healthcare Artificial Intelligence Frontier & Deep Tech Climate & Sustainability Fintech
Regions: Global

Availability

Currently deploying: Not published

Portfolio and track record

Recorded notable exits: Atai

Portfolio context

Notable portfolio companies include: Koko: Details not provided. Duplo: Details not provided. Aura: Details not provided. Centenera: Details not provided. Terran: Neuropsychiatric therapeutics platform. Rarecells: Early cancer diagnosis using circulating tumor-cell isolation and ISET technology. Yassir: Details not provided. Atai: Therapeutics platform developing mental health treatments; noted for a Series B exit at IPO. Twelve: Climate-tech company converting CO2 into chemicals. Advano: Silicon-carbon composite anode materials for advanced lithium-ion batteries. Ovax: Details not provided. Mile High Labs: Hemp-derived cannabinoid manufacturing.

Connected ecosystem